Sheets L
University of California, San Francisco.
Nurs Clin North Am. 1989 Dec;24(4):881-9.
Liver transplantation celebrated its twenty-fifth anniversary in 1988. However, only in the last decade has it been accepted as a viable treatment alternative for patients with end-stage liver disease. There currently are over 70 centers in the United States with liver transplant programs. Over 1500 transplants were performed in 1988, and there were 644 people awaiting suitable liver donors, with an average of 150 to 200 patients added to the list each month. This growth has resulted from many factors, including improved operative techniques and anesthetic management, immunosuppressive therapies, and improvements in donor recovery, which has served to increase the acceptable organs available for transplantation. The future of liver transplantation, however, may be somewhat uncertain. Will the cost of patient care continue to be supported by the economy? The goal of liver transplantation is simple: to provide the patient with a better quality and longer life. The question remains, is this a goal that society will deem financially feasible?
肝移植在1988年迎来了其二十五周年纪念。然而，直到最近十年，它才被公认为是终末期肝病患者可行的治疗选择。目前美国有70多个中心开展肝移植项目。1988年进行了超过1500例移植手术，有644人在等待合适的肝脏供体，每月平均有150至200名患者加入等待名单。这种增长源于多种因素，包括手术技术和麻醉管理的改进、免疫抑制疗法以及供体获取方面的改善，这些都增加了可用于移植的合格器官数量。然而，肝移植的未来可能有些不确定。患者护理的费用是否会继续得到经济支持？肝移植的目标很简单：为患者提供更高质量和更长的生命。问题仍然是，这是否是一个社会认为在经济上可行的目标？
